Latest Breaking News On - Pediatric growth hormone deficiency - Page 9 : comparemela.com

Genexine's Long-acting Anemia Treatment GX-E4 Phase 3 Clinical Trial Interim Result Is Presented at WCN2023, Confirmed Non-inferiority Compared to Mircera

SEOUL, South Korea (BUSINESS WIRE) A clinical-staged proprietary platform technology biotech company Genexine (KQ 095700, CEO Neil Warma) and its Asian regional partner, KG Bio unveiled the interim results of phase 3 clinical trial of GX-E4 (Efepoetin alfa), a candidate for CKD (Chronic Kidney Disease) induced ane.

IndonesiaSeoulSoult ukpyolsiSouth koreaRoche mirceraGenexine incWorld congressInternational society for nephrologyKorean financial services commissionChronic kidney diseaseMethoxy polyethylene glycol epoetinErythropoiesis stimulating agentKidney diseaseImproving global outcomeInternational societyPediatric growth hormone deficiency

Additional Data on Lumos OraGrowtH Trials Presented

Oral Presentation Highlighting Data on 15 Subjects from OraGrowtH212 Trial Supportive of Conclusions from Interim Data Analysis Baseline Characteristics.

ChileBuenos airesDistrito federalArgentinaTexasUnited statesErick hawkinsFernando cassorlaLisa millerAlison lunsfordLumos pharmaUniversity of chileInternational meeting of pediatric endocrinologyLumos pharma incNasdaqOral presentation highlighting data

Additional Data on Lumos OraGrowtH Trials Presented at International Meeting of Pediatric Endocrinology

Additional Data on Lumos OraGrowtH Trials Presented at International Meeting of Pediatric Endocrinology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Buenos airesDistrito federalArgentinaTexasUnited statesErick hawkinsLisa millerlumos pharmaFernando cassorlaAlison lunsfordLumos pharmaUniversity of chiledate timeInternational meeting of pediatric endocrinologyLumos pharma incNasdaqPresentation highlighting dataInterim data

Additional Data on Lumos OraGrowtH Trials Presented at International Meeting of Pediatric Endocrinology

ChileBuenos airesDistrito federalArgentinaTexasUnited statesErick hawkinsFernando cassorlaLisa millerAlison lunsfordLumos pharmaUniversity of chileInternational meeting of pediatric endocrinologyLumos pharma incNasdaqPresentation highlighting data

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.